Primary Combined Hepatocellular-Cholangiocarcinoma: A Case of Underdiagnosed Primary Liver Cancer

Combined hepatocellular-cholangiocarcinoma (CHC) is a rare primary tumor of the liver. Histologically, it comprises components of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) but is associated with a worse prognosis. International guidelines regarding its management are scarce, with surgical management (major hepatectomy) being the treatment of choice. In this report, we present a challenging case of a 73-year-old male with primary CHC who was not a surgical candidate but underwent hepatic artery radioembolization instead.

[1]  T. Baker,et al.  Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma , 2020, Gastrointestinal Tumors.

[2]  D. Adler,et al.  Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study. , 2019, The American journal of gastroenterology.

[3]  Hao Yang,et al.  Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends , 2019, World Journal of Surgical Oncology.

[4]  P. Ross,et al.  Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions , 2018, Journal of hepatocellular carcinoma.

[5]  Zhanguo Zhang,et al.  Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review , 2018, BMC Cancer.

[6]  Kathryn J Fowler,et al.  Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  R. Xu,et al.  Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma , 2017, World journal of hepatology.

[8]  Haitao Zhao,et al.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed. , 2016, World journal of gastroenterology.

[9]  Kathryn J Fowler,et al.  Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy , 2015, Annals of Surgical Oncology.

[10]  R. Groeschl,et al.  Transplantation versus resection for patients with combined hepatocellular carcinoma–cholangiocarcinoma , 2013, Journal of surgical oncology.

[11]  Y. Chao,et al.  Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[12]  P. Hosein,et al.  Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[14]  K. Ishak,et al.  Combined hepatocellular‐cholangiocarcinoma. A histologic and immunohistochemical study , 1985, Cancer.